Tag: HRS 2021
Human-monitored ECG outperforms AI in detection of significant arrhythmias
Long-term continuous electrocardiogtraphy (LT-ECG), coupled with oversight by a physician, significantly outperforms algorithm-dependent mobile cardiac telemetry (MCT) in the detection of significant arrhythmias according...
HRS 2021: Early rhythm control benefits AF patients with heart failure
Rhythm control therapy offers a clinical benefit when initiated within one year of a diagnosis of atrial fibrillation (AF) in patients with signs or...
HRS 2021: CABANA analysis points to economic case for catheter ablation
A new analysis of the CABANA (Catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation) suggests that catheter ablation offers positive economic outcomes compared...
HRS 2021: Early VT catheter ablation beats medical therapy in patients...
Results of the PAUSE-SCD trial show a significant reduction in risk of ventricular tachycardia (VT) recurrence, cardiovascular hospitalisation, and death when catheter ablation is...
HRS 2021: DOACs reduce risk of stroke in patients undergoing left...
Use of direct oral anticoagulants (DOACs) in patients undergoing ventricular tachycardia radio frequency ablation (RFA) is associated with a reduced risk of transient ischaemic...